期刊文献+
共找到14篇文章
< 1 >
每页显示 20 50 100
Alpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease 被引量:3
1
作者 Clara Antoury Rocio Lopez +2 位作者 Nizar Zein James K Stoller Naim Alkhouri 《World Journal of Hepatology》 CAS 2015年第10期1427-1432,共6页
AIM:To evaluate the association between alpha-1 antitrypsin deficiency(A1ATD) and hepatocellular carcinoma(HCC) in patients with end-stage liver disease(ESLD).METHODS:Patients with cirrhosis and ESLD referred to the C... AIM:To evaluate the association between alpha-1 antitrypsin deficiency(A1ATD) and hepatocellular carcinoma(HCC) in patients with end-stage liver disease(ESLD).METHODS:Patients with cirrhosis and ESLD referred to the Cleveland Clinic Foundation for liver transplantation between 2003 and 2014 were included in the study(N = 675). ESLD was defined as having histological features of cirrhosis and/or radiological evidence of cirrhosis in the context of portal hypertension(ascites,variceal bleeding,thrombocytopenia,or hepatic encephalopathy). A1 ATD was diagnosed using phenotype characterization(MZ or ZZ),liver biopsy detection of PAS-positive diastaseresistant(PAS+) globules,or both. Patients with other causes of liver diseases such as hepatitis C virus(HCV),alcoholic liver disease and non-alcoholic steatohepatitis(NASH) or NASH were also included in the study. HCC was diagnosed by using imaging modalities,biopsy findings,or explanted liver inspection. Follow-up time was defined as the number of years from the diagnosis of cirrhosis to the diagnosis of hepatocellular carcinoma,or from the diagnosis of cirrhosis to the last follow up visit. The rate of HCC was assessed using time-tointerval analysis for interval censored data.RESULTS:This study included 675 patients. 7% of subjects had A1ATD(n = 47). Out of all subjects who did not have A1 ATD,46% had HCV,17% had alcoholic liver disease,19% had NASH and 18% had another primary diagnosis. Of the 47 subjects with A1 ATD,15 had a primary diagnosis of A1ATD(PI*ZZ phenotype and PAS+ globules),8 had a PI*MZ phenotype alone,14 had PAS+ alone,and 10 had both the PI*MZ phenotype and PAS+. Median follow-up time was 3.4(25th,75 th percentiles:1,5.2) years. The overall rate of hepatocellular carcinoma in all subjects was 29%(n = 199). In the A1 ATD group,the incidence rate of HCC was 8.5% compared to 31% in the group of patients with other causes of cirrhosis(P = 0.001). Patients with ESLD due to A1 ATD had the lowest yearly cumulative rate of hepatocellular carcinoma at 0.88% per year compared to 2.7% for those with HCV cirrhosis,1.5% in patients with NASH and 0.9% in alcohol-induced liver disease(P < 0.001).CONCLUSION:Within this group of patients with ESLD,there was no significant association between A1 ATD and increased risk of HCC. 展开更多
关键词 HEPATOcELLULAR carcinoma LIVER cirrhosis END-STAGE LIVER disease Hepatitis c virus Alpha-1antitrypsin deficiency
暂未订购
A C1-inhibitor rare mutation: Early diagnosis of hereditary angioedema in a paediatric patient
2
作者 Maria Cristina Maggio Piero Sammarco +1 位作者 Carmelo Fabiano Giovanni Corsello 《Open Journal of Pediatrics》 2013年第1期42-44,共3页
Hereditary angioedema secondary to C1-inhibitor deficiency is a rare autosomal dominant disorder characterized by a deficiency of C1 esterase inhibitor.An eight-year-old girl showed periorbital painless swelling, diag... Hereditary angioedema secondary to C1-inhibitor deficiency is a rare autosomal dominant disorder characterized by a deficiency of C1 esterase inhibitor.An eight-year-old girl showed periorbital painless swelling, diagnosed as ethmoiditis. A craniofacial scan did not evidence a paranasal sinus involvement, C1INH levels were undetectable, with low C4 levels: 7.6 mg/dl and C1INH: <8.46 mg/dl. The genetic study identified a rare mutation of the C1INH gene. This clinical report is of relieve because paediatric cases described in literature are rare, did not presented a positive family history, and received a diagnosis after many attacks. Furthermore our girl received a prompt diagnosis of HAE at the first attack of angioedema. 展开更多
关键词 HEREDITARY ANGIOEDEMA c1-inhibitor deficiency
暂未订购
CXCR5、sPD-1、Hcy在AIDS患者治疗过程中的动态变化及临床意义 被引量:4
3
作者 石鹏辉 范伟光 +3 位作者 张珍 苏苗苗 孟娟 路新利 《检验医学》 CAS 2022年第2期103-107,共5页
目的探讨获得性免疫缺陷综合征(AIDS)患者抗逆转录病毒治疗(ART)过程中血清趋化因子受体5(CXCR5)、可溶性程序性细胞死亡受体-1(sPD-1)、同型半胱氨酸(Hcy)的变化及临床意义。方法选取AIDS患者120例(AIDS组),分别在AIDS患者治疗前1 d及... 目的探讨获得性免疫缺陷综合征(AIDS)患者抗逆转录病毒治疗(ART)过程中血清趋化因子受体5(CXCR5)、可溶性程序性细胞死亡受体-1(sPD-1)、同型半胱氨酸(Hcy)的变化及临床意义。方法选取AIDS患者120例(AIDS组),分别在AIDS患者治疗前1 d及治疗后3、6、12个月检测其人类免疫缺陷病毒(HIV)-1载量、CD4+T细胞绝对数及CXCR5、sPD-1、Hcy、血脂[三酰甘油(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)]水平;以体检健康者45名作为正常对照组。采用Pearson相关分析评估各项指标与CD4+T细胞绝对数、HIV-1载量的相关性。结果AIDS组治疗前sPD-1和Hcy水平均显著高于正常对照组(P<0.01),CXCR5、CD4+T细胞绝对数均显著低于正常对照组(P<0.01)。与治疗前比较,随着ART时间的延长,AIDS患者CD4+T细胞绝对数、CXCR5水平均显著升高(P<0.05),在治疗6个月时达到峰值;Hcy、TC、TG、LDL-C在治疗12个月时显著升高(P<0.05);HDL-C无变化;治疗3个月时HIV-1载量开始降低(P<0.05),治疗6个月时降低更为显著(P<0.05);治疗12个月时血清sPD-1水平显著降低(P<0.05)。Pearson相关分析结果显示,CD4+T细胞绝对数与CXCR5、Hcy水平均呈正相关(r值分别为0.192、0.401,P<0.05),与sPD-1呈负相关(r=-0.708,P<0.05);HIV-1载量与CXCR5、Hcy均呈负相关(r值分别为-0.682、-0.318,P<0.05),与sPD-1呈正相关(r=0.368,P<0.05)。结论动态监测AIDS患者ART过程中CD4+T细胞绝对数、HIV-1载量、CXCR5、sPD-1、Hcy和血脂的变化,有助于及时了解HIV感染的进展情况。 展开更多
关键词 趋化因子受体5 可溶性程序性死亡受体-1 同型半胱氨酸 获得性免疫缺陷综合征 抗逆转录病毒治疗
暂未订购
Hereditary Angioedema in Pregnancy and Management without Recombinant Human C1-INH
4
作者 Natália Paseto Pilati Maria Alexandrina Zanatta +6 位作者 Daniele Camila Maltauro Gabrielle Behenck Edimárlei Gonsales Valério Fernanda Oliveira Castilhos Eduardo Vettorazzi-Stuczynski Daniela Vanessa Vettori Janete Vettorazzi 《Open Journal of Obstetrics and Gynecology》 2021年第11期1470-1476,共7页
A pregnant woman diagnosed with type 1 angioedema seeks care at a public hospital for planning the delivery. This report presents ways to prevent and manage an acute HAE crisis during childbirth and early postpartum w... A pregnant woman diagnosed with type 1 angioedema seeks care at a public hospital for planning the delivery. This report presents ways to prevent and manage an acute HAE crisis during childbirth and early postpartum without the availability of first-line medications, such as plasma-derived human C1-INH concentrate. 展开更多
关键词 Hereditary Angioedema (HAE) c1-inhibitor High-Risk Pregnancy PROPHYLAXIS
暂未订购
脾气虚证模型大鼠股四头肌线粒体未折叠蛋白反应及CHOP蛋白表达的研究 被引量:2
5
作者 刘文俊 赵秋宇 +3 位作者 马天驰 谢鑫 张立德 单德红 《中华中医药杂志》 CAS CSCD 北大核心 2021年第4期2299-2303,共5页
目的:通过观察脾气虚证模型大鼠股四头肌线粒体应激反应元件(CHOP)及线粒体未折叠蛋白反应(UPRmt)的变化,从UPRmt方面研究"脾气虚四肢不用"的机制。方法:运用饮食失节+劳倦法复制脾气虚证大鼠模型,随机分为对照组和脾气虚模型... 目的:通过观察脾气虚证模型大鼠股四头肌线粒体应激反应元件(CHOP)及线粒体未折叠蛋白反应(UPRmt)的变化,从UPRmt方面研究"脾气虚四肢不用"的机制。方法:运用饮食失节+劳倦法复制脾气虚证大鼠模型,随机分为对照组和脾气虚模型组(模型组),造模成功后取股四头肌,比色法检测三磷酸腺苷(ATP)、过氧化氢(H2O2)水平及呼吸链复合体(CⅠ~CⅣ)酶活性;免疫印迹(Western blot)法检测CⅠ~CⅣ、热休克蛋白70/60(HSP70/60)、Lon蛋白酶(LonP)/Clp蛋白酶(ClpP)及CHOP蛋白表达。结果:比色结果显示,与对照组比较,模型组股四头肌ATP含量下降(P<0.05)、H2O2含量升高(P<0.05);CⅡ、CⅣ酶活性下降(P<0.05,P<0.01)。Westernblot结果显示,与对照组比较,模型组股四头肌CⅠ蛋白表达升高(P<0.01),CⅡ蛋白表达下降(P<0.01),HSP60蛋白表达下降(P<0.01),ClpP蛋白表达升高(P<0.01);CHOP蛋白表达下降(P<0.05)。结论:"脾气虚四肢不用"可能与CHOP抑制所致UPRmt紊乱有关。 展开更多
关键词 脾气虚证 股四头肌 线粒体未折叠蛋白反应 热休克蛋白 Lon蛋白酶 clp蛋白酶 线粒体应激反应元件
原文传递
益气舒心丸对冠心病PCI术后患者左心室舒张功能的影响和机制研究
6
作者 贺青军 陈伟强 +3 位作者 罗智敏 庞建萍 欧惠珍 刘照宏 《实用中西医结合临床》 2016年第6期1-3,10,共4页
目的:观察益气舒心丸对冠心病PCI术后患者左心室舒张功能的影响并探讨相关机制。方法:将符合诊断标准的102例冠心病患者随机分为两组。对照组50例予西医常规治疗,不加用任何具有益气或活血作用的中药或中成药;治疗组52例在西医治疗基础... 目的:观察益气舒心丸对冠心病PCI术后患者左心室舒张功能的影响并探讨相关机制。方法:将符合诊断标准的102例冠心病患者随机分为两组。对照组50例予西医常规治疗,不加用任何具有益气或活血作用的中药或中成药;治疗组52例在西医治疗基础上,加用益气舒心丸,治疗6个月。测定治疗前后气虚证、血瘀证计分和一氧化氮(NO)、hs-CRP、内皮素-1(ET-1)等指标的变化。同时,治疗前后行彩色多谱勒超声心动图测定左心室舒张功能等指标变化。结果:治疗组的气虚证、血瘀证计分较治疗前明显降低,优于对照组(P<0.05);治疗组的ET-1、hs-CRP较治疗前明显降低,NO较治疗前升高,均优于对照组(P<0.05);治疗组的超声心动图测定左心室舒张功能等指标较对照组改善明显,差异有显著统计学意义(P<0.05)。结论:益气舒心丸可改善冠心病PCI术后患者气虚血瘀状态,改善血管内皮功能,增加舒张期心肌顺应性,从而改善左心室舒张功能。 展开更多
关键词 PcI术后 气虚证 血瘀证 益气舒心丸 左心室舒张功能 一氧化氮、hs-cRP、内皮素-1
暂未订购
四神丸调控p38 MAPK/JNK/TRPV1信号通路改善脾肾阳虚型腹泻型肠易激综合征大鼠的内脏敏感性 被引量:9
7
作者 黎思琪 胡运莲 +4 位作者 苏成霞 萧闵 江晓翠 文娜 章茜 《中国实验方剂学杂志》 CAS CSCD 北大核心 2024年第21期10-18,共9页
目的:探讨四神丸改善腹泻型肠易激综合征大鼠的内脏敏感性的作用及其可能机制。方法:40只雄性SPF级大鼠随机分为空白组、模型组、四神丸低、高剂量组(3.51、7.02 g·kg^(-1))、培菲康组(0.54 g·kg^(-1))。除空白组外,其余均以... 目的:探讨四神丸改善腹泻型肠易激综合征大鼠的内脏敏感性的作用及其可能机制。方法:40只雄性SPF级大鼠随机分为空白组、模型组、四神丸低、高剂量组(3.51、7.02 g·kg^(-1))、培菲康组(0.54 g·kg^(-1))。除空白组外,其余均以母子分离刺激+番泻叶水煎剂灌胃构建脾肾阳虚型腹泻型肠易激综合征大鼠模型。给予相应药物干预后:观察大鼠一般情况,测量大鼠6 h排便颗粒及腹壁撤退反射实验(AWR)最小容量阈值,酶联免疫吸附测定法检测大鼠血清肿瘤坏死因子-α(TNF-α)、胃泌素(GAS)、皮质酮(CORT)、促肾上腺皮质激素(ACTH)含量,苏木素-伊红(HE)染色法观察大鼠结肠组织形态,甲苯胺蓝染色法观察大鼠结肠组织肥大细胞脱颗粒情况,蛋白免疫印迹法(Western blot)检测大鼠结肠组织p38丝裂原活化蛋白激酶(p38 MAPK)、c-Jun氨基末端激酶(JNK)、瞬时感受器电位香草酸受体1(TRPV1)、蛋白酶激活受体2(PAR2)蛋白表达,免疫组化法检测结肠组织TRPV1蛋白含量,免疫荧光法检测结肠组织神经肽P物质(SP)和降钙素基因相关肽(CGRP)蛋白阳性表达。结果:与空白组比较,模型组大鼠6 h排便颗粒显著增加(P<0.01),AWR最小容量阈值显著降低(P<0.01),TNF-α含量显著升高(P<0.01),GAS、CORT、ACTH含量明显降低(P<0.05,P<0.01),肥大细胞脱颗粒率升高(P<0.01),TRPV1的阳性表达明显升高(P<0.05),SP、CGRP蛋白阳性表达明显升高(P<0.05,P<0.01),p38 MAPK、JNK、TRPV1、PAR2蛋白表达量均显著升高(P<0.01);与模型组比较,四神丸高剂量组AWR最小容量阈值显著升高(P<0.01),四神丸高剂量组、培菲康组排便频率明显下降(P<0.05,P<0.01),TNF-α含量明显降低(P<0.05,P<0.01),GAS、CORT、ACTH含量明显升高(P<0.05,P<0.01),肥大细胞脱颗粒率下降(P<0.01),TRPV1阳性表达下降(P<0.05),SP、CGRP表达水平明显降低(P<0.05,P<0.01),p38 MAPK、JNK、TRPV1、PAR2蛋白表达量明显降低(P<0.05,P<0.01)。结论:四神丸可改善脾肾阳虚型腹泻型肠易激综合征大鼠的内脏敏感性,其机制可能与调控p38 MAPK/JNK/TRPV1信号通路相关。 展开更多
关键词 腹泻型肠易激综合征 脾肾阳虚证 四神丸 p38丝裂原活化蛋白激酶(p38 MAPK)/c-Jun氨基末端激酶(JNK)/瞬时感受器电位香草酸受体1(TRPV1)通路 内脏敏感性
原文传递
Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis via AMPK and mTOR regulation 被引量:5
8
作者 David Fernández-Ramos Fernando Lopitz-Otsoa +17 位作者 Laura Delacruz-Villar Jon Bilbao Martina Pagano Laura Mosca Maider Bizkarguenaga Marina Serrano-Macia Mikel Azkargorta Marta Iruarrizaga-Lejarreta Jesús Sot Darya Tsvirkun Sebastiaan Martijn van Liempd Felix M Goni Cristina Alonso María Luz Martínez-Chantar Felix Elortza Liat Hayardeny Shelly C Lu JoséM Mato 《World Journal of Gastroenterology》 SCIE CAS 2020年第34期5101-5117,共17页
BACKGROUND Arachidyl amido cholanoic acid(Aramchol)is a potent downregulator of hepatic stearoyl-CoA desaturase 1(SCD1)protein expression that reduces liver triglycerides and fibrosis in animal models of steatohepatit... BACKGROUND Arachidyl amido cholanoic acid(Aramchol)is a potent downregulator of hepatic stearoyl-CoA desaturase 1(SCD1)protein expression that reduces liver triglycerides and fibrosis in animal models of steatohepatitis.In a phase IIb clinical trial in patients with nonalcoholic steatohepatitis(NASH),52 wk of treatment with Aramchol reduced blood levels of glycated hemoglobin A1c,an indicator of glycemic control.AIM To assess lipid and glucose metabolism in mouse hepatocytes and in a NASH mouse model[induced with a 0.1%methionine and choline deficient diet(0.1MCD)]after treatment with Aramchol.METHODS Isolated primary mouse hepatocytes were incubated with 20μmol/L Aramchol or vehicle for 48 h.Subsequently,analyses were performed including Western blot,proteomics by mass spectrometry,and fluxomic analysis with 13C-uniformly labeled glucose.For the in vivo part of the study,male C57BL/6J mice were randomly fed a control or 0.1MCD for 4 wk and received 1 or 5 mg/kg/d Aramchol or vehicle by intragastric gavage for the last 2 wk.Liver metabolomics were assessed using ultra-high-performance liquid chromatography-time of flight-MS for the determination of glucose metabolism-related metabolites.RESULTS Combination of proteomics and Western blot analyses showed increased AMPK activity while the activity of nutrient sensor mTORC1 was decreased by Aramchol in hepatocytes.This translated into changes in the content of their downstream targets including proteins involved in fatty acid(FA)synthesis and oxidation[PACCα/β(S79),SCD1,CPT1A/B,HADHA,and HADHB],oxidative phosphorylation(NDUFA9,NDUFB11,NDUFS1,NDUFV1,ETFDH,and UQCRC2),tricarboxylic acid(TCA)cycle(MDH2,SUCLA2,and SUCLG2),and ribosome(P-p70S6K[T389]and P-S6[S235/S236]).Flux experiments with 13Cuniformely labeled glucose showed that TCA cycle cataplerosis was reduced by Aramchol in hepatocytes,as indicated by the increase in the number of rounds that malate remained in the TCA cycle.Finally,liver metabolomic analysis showed that glucose homeostasis was improved by Aramchol in 0.1MCD fed mice in a dose-dependent manner,showing normalization of glucose,G6P,F6P,UDP-glucose,and Rbl5P/Xyl5P.CONCLUSION Aramchol exerts its effect on glucose and lipid metabolism in NASH through activation of AMPK and inhibition of mTORC1,which in turn activate FAβ-oxidation and oxidative phosphorylation. 展开更多
关键词 Nonalcoholic fatty liver disease STEATOHEPATITIS Methionine and choline deficient diet Tricarboxylic acid cycle Hemoglobin A1c Stearoyl-coA desaturase 1
暂未订购
Diagnosis and management of angioedema with abdominal involvement:A gastroenterology perspective 被引量:1
9
作者 Ugochukwu C Nzeako 《World Journal of Gastroenterology》 SCIE CAS CSCD 2010年第39期4913-4921,共9页
Abdominal involvement in angioedema is often a challenge to diagnose.Acute onset abdominal pain is its most common presenting symptom,and misdiagnosis may lead to unnecessary surgical intervention.Familiarity with the... Abdominal involvement in angioedema is often a challenge to diagnose.Acute onset abdominal pain is its most common presenting symptom,and misdiagnosis may lead to unnecessary surgical intervention.Familiarity with the types and presentations of angioedema can be invaluable to clinicians as they consider the differential diagnoses of a patient presenting with abdominal pain. Detailed personal and family histories,careful physical examination of the patient,combined with knowledge of angioedema types,can help clinicians perform their diagnostic evaluation.An accurate diagnosis is essential in order to provide appropriate treatment to patients with angioedema.Depending upon the diagnosis,treatment may be the avoidance of provoking factors(such as allergens or medications),inhibiting histamine-provoked reactions,or treating C1 esterase inhibitor deficiency. 展开更多
关键词 Acquired ANGIOEDEMA Angiotensin-converting enzyme-induced ANGIOEDEMA Gastrointestinal HEREDITARY ANGIOEDEMA c1 ESTERASE inhibitor deficiency
暂未订购
Vitamin D and Its Association with Glycemic Status in Bangladeshi Adults with Newly Detected Type 2 Diabetes Mellitus
10
作者 Md. Firoj Hossain Tahniyah Haq +3 位作者 Md. Fariduddin Shahjada Selim M. A. Hasanat Md. Shahed-Morshed 《Open Journal of Endocrine and Metabolic Diseases》 2021年第1期1-11,共11页
<div style="text-align:justify;"> <span style="font-family:Verdana;"><strong><em>Background:</em></strong> Very limited data are available regarding the associat... <div style="text-align:justify;"> <span style="font-family:Verdana;"><strong><em>Background:</em></strong> Very limited data are available regarding the association of vitamin D with glycemic status among adults with newly detected type 2 diabetes mellitus (T2DM) in Bangladesh. <strong><em>Objectives:</em></strong> To determine vitamin D status and its association with glycemic status in Bangladeshi adults with newly detected T2DM. <strong><em>Materials and Methods:</em></strong> This cross-sectional study was carried out in 102 newly detected T2DM diagnosed on the basis of the American Diabetes Association 2017 criteria (age: 42.95 ± 10.68 yrs.;m/f: 44/58) and equal number of age and sex matched controls (age: 40.43 ± 11.04 years) recruited consecutively from the Department of Endocrinology, B中央人民政府 to measure serum vitamin D by high performance liquid chromatography method. <strong><em>Results:</em></strong> Both vitamin D deficiency (<20 ng/ml) (87.3% vs. 74.5%, <em>p </em>< 0.03) and severe vitamin D deficiency (<10 ng/ml) (56.2% vs. 26.3%, <em>p</em> < 0.001) were significantly higher in people with T2DM than control population. The mean level of 25(OH)D was significantly lower in adults with T2DM than control population (12.41 ± 6.85 ng/ml vs. 15.74 ± 6.25 ng/ml, <em>p</em> < 0.001). A significant inverse correlation was observed between vitamin D & HbA<span style="white-space:nowrap;"><sub>1</sub></span>c (r = <span style="white-space:nowrap;">&#45;</span>0.249, <em>p</em> = 0.011) in patients with T2DM. HbA<span style="white-space:nowrap;"><sub>1</sub></span>c was linearly associated with vitamin D (<em>β </em>= <span style="white-space:nowrap;">&#45;</span>0.26, <em>p</em> = 0.009) and severe vitamin D deficiency by binary (OR = 1.37, <em>p</em> = 0.003) and multinomial logistic regression (HbA<span style="white-space:nowrap;"><sub>1</sub></span>c ≥ 10%: OR = 4.25, <em>p </em>= 0.04) in people with T2DM after adjustment for age and BMI. <strong>Conclusions:</strong> Severe vitamin D deficiency was positively associated with T2DM and inversely associated with HbA<span style="white-space:nowrap;"><sub>1</sub></span>c in patients with newly detected T2DM.</span> </div> 展开更多
关键词 Vitamin D Type 2 Diabetes Mellitus Vitamin D deficiency Glycated Hemoglobin A1c
暂未订购
Perioperative anesthetic management in pediatric hereditary angioedema;case report
11
作者 M.Nuri Deniz Aylin Incesu +1 位作者 Elvan Erhan Gulden Ugur 《Open Journal of Pediatrics》 2012年第4期294-297,共4页
Hereditary angioedema is a rare but life-threatening disease, usually resulting from upper respiratory tract traumas and stress. In this case report, we present the management of a 14-year-old female patient who was d... Hereditary angioedema is a rare but life-threatening disease, usually resulting from upper respiratory tract traumas and stress. In this case report, we present the management of a 14-year-old female patient who was diagnosed with hereditary angioedema and scheduled to undergo transurethral resection of bladder (TURB) procedure for bladder tumor. She was on prophylactic danazol treatment and prior to the operation the dose of danazol was increased. On the day of the operation, patient was given C1-IHN concentrate and was sedated. In conclusion, hereditary angioedema is a rare disease in which multidisciplinary and aggressive approach during anesthesia would yield successful results. 展开更多
关键词 Hereditary Angioedema c1 Inhibitor deficiency Anesthetic Management and Bladder Tumor
暂未订购
束缚应激大鼠中枢AMPA受体和相关蛋白mRNA表达的变化及逍遥散对其调节作用 被引量:13
12
作者 岳广欣 王竹风 +4 位作者 张巧丽 陈家旭 赵歆 岳利峰 丁杰 《中国中西医结合杂志》 CAS CSCD 北大核心 2007年第12期1110-1115,共6页
目的观察海马及杏仁核α-氨基羟甲基恶唑丙酸(AMPA)受体各亚基和相关调节蛋白在束缚应激状态下的mRNA表达变化及逍遥散的作用。方法使用捆绑的方法制作束缚应激动物模型,并用逍遥散进行干预,分别于7天后和21天后检测模型大鼠海马CA1区、... 目的观察海马及杏仁核α-氨基羟甲基恶唑丙酸(AMPA)受体各亚基和相关调节蛋白在束缚应激状态下的mRNA表达变化及逍遥散的作用。方法使用捆绑的方法制作束缚应激动物模型,并用逍遥散进行干预,分别于7天后和21天后检测模型大鼠海马CA1区、CA3区、齿状回(DG)、杏仁核AMPA受体亚基GluR1-4、N-乙基顺丁烯二酰亚胺敏感性融合蛋白(NSF)、PKC作用蛋白1(PICK1)mRNA表达的情况。结果7天束缚应激状态下,GluR1 mRNA在海马CA1区表达显著下降(P<0.05),在CA3区和杏仁核表达显著上升(均P<0.05),GluR2、GluR3 mRNA在杏仁核(均P<0.05),GluR4 mRNA在CA1区(P<0.01)表达显著增高,NSF、PICK1 mRNA表达在杏仁核有明显增高趋势;逍遥散对CA1区GluR4及杏仁核GluR1、GluR2、GluR3 mRNA表达变化有显著调节作用(P<0.05,P<0.01)。21天束缚应激状态下,CA1区GluR4、DG的GluR2 mRNA表达显著下降(均P<0.05),杏仁核GluR1 mRNA表达显著增强(P<0.01);逍遥散对CA1区GluR1、GluR4 mRNA表达变化有显著调节作用(均P<0.05)。结论短期重复应激对于AMPA受体各亚基mRNA表达的影响较强,逍遥散对AMPA受体各亚基mRNA表达的调节在海马CA1区和杏仁核较明显。 展开更多
关键词 束缚应激 抑郁症 肝郁脾虚证 α-氨基羟甲基恶唑丙酸受体 N-乙基顺丁烯二酰亚胺敏感性融合蛋白 PKc作用蛋白1 逍遥散
暂未订购
益气通瘀汤联合西药治疗稳定型心绞痛临床研究 被引量:3
13
作者 何正飞 熊礼凤 陈志云 《新中医》 CAS 2020年第5期59-61,共3页
目的:观察益气通瘀汤联合西药治疗气虚血瘀型稳定型心绞痛的临床疗效。方法:选取120例确诊为气虚血瘀型稳定型心绞痛患者作为研究对象,随机分为治疗组和对照组,每组60例。对照组给予西医常规治疗,治疗组在对照组治疗的基础上联合益气通... 目的:观察益气通瘀汤联合西药治疗气虚血瘀型稳定型心绞痛的临床疗效。方法:选取120例确诊为气虚血瘀型稳定型心绞痛患者作为研究对象,随机分为治疗组和对照组,每组60例。对照组给予西医常规治疗,治疗组在对照组治疗的基础上联合益气通瘀汤治疗,对比2组患者治疗后的临床症状体征积分、心绞痛改善情况及血清内皮素-1(ET-1)、同型半胱氨酸(Hcy)、超敏C-反应蛋白(hs-CRP)水平及临床疗效。结果:治疗后,2组患者的临床症状体征积分、心绞痛发作次数及持续时间、ET-1、Hcy、hs-CRP水平均较治疗前明显下降,差异有统计学意义(P<0.05)。治疗后组间对比,治疗组临床症状体征积分、心绞痛发作次数及持续时间、ET-1、Hcy、hs-CRP水平均低于对照组,差异有统计学意义(P<0.05)。治疗组临床总有效率为91.7%,明显高于对照组的75.0%(P<0.05)。结论:益气通瘀汤联合西药治疗气虚血瘀型稳定型心绞痛临床疗效确切,较单用西药治疗能更好的改善患者的症状体征,降低患者血清ET-1、Hcy、hs-CRP水平,提高临床疗效,具有临床应用及研究价值。 展开更多
关键词 稳定型心绞痛 益气通瘀汤 气虚血瘀型 中西医结合治疗 内皮素-1(ET-1) 同型半胱氨酸(Hcy) 超敏c-反应蛋白(hs-cRP)
原文传递
Clinical and laboratory survey of 65 Chinese patients with Leigh syndrome 被引量:17
14
作者 YANG Yan-ling SUN Fang +12 位作者 ZHANG Yao QIAN Ning YUAN Yun WANG Zhao-xia QI Yu XIAO Jiang-xi WANG Xiao-ying QI Zhao-yue ZHANG Yue-hua JIANG Yu-wu BAO Xin-hua QIN Jiong WU Xi-ru 《Chinese Medical Journal》 SCIE CAS CSCD 2006年第5期373-377,共5页
Background Leigh syndrome is an inherited neurodegenerative disease that emerges in infancy and childhood and presents with a clinically heterogeneous variety of neuromuscular and non-neuromuscular disorders. It can r... Background Leigh syndrome is an inherited neurodegenerative disease that emerges in infancy and childhood and presents with a clinically heterogeneous variety of neuromuscular and non-neuromuscular disorders. It can result from the inheritance of mutations in either nuclear or mitochondrial DNA. In the current study, we performed a retrospective study in 65 patients in order to investigate the clinical and genetic characteristics of Leigh syndrome in Chinese patients. Methods Sixty-five unrelated cases (35 men and 30 women) who were hospitalized in the past 12 years were reviewed. Diagnosis was based on both the clinical presentation and the characteristic neuropathologic findings of bilateral symmetric necrotizing lesions in the basal ganglia and brain stem as detected using cranial computed tomography (CT) scan or magnetic resonance imaging (MRI). The differential diagnosis of organic acidurias and fatty acid IS-oxidation defects were performed. Specific point mutations and deletions in mitochondrial DNA (T8993G, T8993C, T9176C, A8344G, A3243G) were screened by PCR-restriction analysis and Southern blot. The SURF1 gene was sequenced. Skeletal muscle biopsies were performed in 17 (26.2%) of the patients. The diagnosis was confirmed by autopsy in 6 (9.2%) patients. Results The patients had various forms of metabolic encephalomyopathy. Filly-nine (90.8%) of the patients had the typical neuroradiological features of Leigh syndrome, including symmetrical necrotizing lesions scattered within the basal ganglia, thalamus and brain stem. Twenty (30.8%) patients were confirmed by genetic, biochemical analysis and autopsy. Specific point mutations in mitochondrial DNA were found in 5 cases (7.7%). Of these, the A8344G mutation was detected in 2 patients. The T8993G T8993C, and A3243G point mutations were identified in 3 other patients, respectively. SURF1 mutations associated with cytochrome c oxidase deficiency were identified in 8 (12.3%) families by DNA sequencing. A G604C mutation was identified in 6 (9.2%) patients. The genotypes of 52 patients remained unknown. Conclusions Leigh syndrome presents as a diverse array of clinical features and can result from specific mutations in nuclear or mitochondrial DNA. In this study, SURF1 mutations associated with cytochrome c oxidase deficiency were identified in 8 (12.3%) out of 65 patients with Leigh syndrome. It indicates that SURF1 mutations might be a common cause of Leigh syndrome in China. The etiology of Leigh syndrome in Chinese patients represents a persistent challenge to clinicians. 展开更多
关键词 Leigh syndrome mitochondrial genes cytochrome c oxidase deficiency SURF1 gene
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部